Lexington Hill Partners, LLC

Position in NVS — Novartis AG

CIK 2111980 DALLAS, TX

Position in NVS

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$261,722

-$15,672 QoQ

Shares Held

1,670

-8.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.53%

of 13F equity value

Holder Rank

#1,201

of 1,603 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Lexington Hill Partners, LLC holds $1,858,828 across 5 Drug Manufacturers - General names. NVS ranks #5 (14.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	550	$659,686
2	ABBV	AbbVie Inc.	1,288	$324,112
3	JNJ	Johnson & Johnson	1,237	$314,160
4	MRK	Merck & Co., Inc.	2,328	$299,148
5	NVS	Novartis AG This page	1,670	$261,722

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$261,722	1,670	-8.0%	Shares	Sole	2026-07-08
2026-03-31	$277,394	1,816	—	Shares	Sole	2026-04-16
No filing history on record for this holder in this stock.